Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

m.

Merck forward-looking statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2006, and in its periodic reports on Form 10-Q and Form 8-K, which the Company incorporates by reference.

Prescribing information and patient product information for JANUVIA and JANUMET are attached.

JANUVIA(TM) and JANUMET(TM) are trademarks of Merck & Co., Inc. -0-

JANUVIA(TM)(sitagliptin) Tablets                     9762701


    HIGHLIGHTS OF PRESCRIBING INFORMATION


    These highlights do not include all the information needed to use

JANUVIA safely and effectively. See full prescribing information for

JANUVIA.


    JANUVIA(TM) (sitagliptin) Tablets


    Initial U.S. Approval: 2006


    INDICATIONS AND USAGE


    JANUVIA is indicated as an adjunct to diet and exercise to improve

glycemic control in patients with type 2 diabetes mellitus (type 2

diabetes). JANUVIA is indicated for:


    --  Monotherapy (1.1)


    --  Combination therapy with metformin or a peroxisome

        proliferator-activated receptor ga
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release
Formulation of Bromocriptine Mesylate) Accepted for Poster
Presentation at American Diabetes Association 67th Scientific
Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive
Heart Failure Presented at Late-Breaking Session of Heart Failure
Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology
Shown to Significantly Lower Instances of Severe Retinopathy of
Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at
American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR
Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas
Investigational Novel Treatment, Tolvaptan, Published in Journal of
the American Medical Association and Featured in ACCs Late
Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study
of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial
Combination Therapy with Januvia (sitagliptin) and Metformin Led to
Improvement in Markers of Beta Cell Function in Patients with Type
2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker
Presented at American Society of Hypertension Twenty-Second Annual
Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker
Presented at American Society of Hypertension Twenty-Second Annual
Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant
Recipients to Be Released at International Heart and Lung
Transplant Meeting
Post Your Comments:
(Date:6/18/2013)... June 18, 2013 Decision Resources, one of the ... issues, finds that, over the past 12 months, 25 percent ... , Germany , Italy ... United Kingdom ) have been required to change the ... patients, primarily to reduce costs. Additionally, more than 40 percent ...
(Date:6/18/2013)... , June 18, 2013 Today, Wall ... (NASDAQ: GILD ), Health Management Associates Inc. (NYSE: ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), ... these reports free of charge - including full price targets, ... Gilead Sciences, Inc. Research Report On ...
(Date:6/18/2013)... 2013 Apama Medical, a privately held ... next-generation atrial fibrillation technologies, today announced the issuance ... Patent and Trademark Office (USPTO), titled "Low Profile ... for use on expandable structures such as balloons ... "We are grateful to the NSF ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
... 2011 Reportlinker.com announces that a new market ... Pharmaceutical Distributors - Europe ... This register contains information about 2063 ... includes the following information about the distributors: ...
... Reportlinker.com announces that a new market research ... Pharmaceutical Manufacturers - Europe ... This register contains information about 3251 manufacturers ... the following details of the manufacturers: ...
Cached Medicine Technology:
(Date:6/19/2013)... Woburn, MA (PRWEB) June 19, 2013 ... brand of advanced carpet cleaning machines, including reliable ... highly ranked grout cleaning machine systems , ... the XTreme Power® XPH-5900I for auto detailing professionals. ... the 5000 series of Daimer® models, is ideal ...
(Date:6/19/2013)... UK (PRWEB) June 19, 2013 Tools4ever, ... is sponsoring today's event, at which it will be ... as well as giving further insight into its leading-edge ... for IT & business professionals specialising in IDM infrastructure ... range of markets including the public sector, banking, finance ...
(Date:6/19/2013)... Men often deal with gastrointestinal health issues ... to what they are consuming on a daily basis. With ... and supplier of Siberian pine nut oil, PineNutOil.org , ... healing elements within pine nut oil. , Stomach ... ulcers within the gastrointestinal tract that are usually acidic and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Indosoft ... Center ACD for Asterisk, announced today the ... 5.7. This enhancement offers improved options for extracting, ... dashboards for effective contact center management. , Large ... real-time captured as it happens from the call ...
(Date:6/19/2013)... 19, 2013 On 31 May 2013, ... about involuntarily detaining patients, a proposal put forward from ... and mental health service provider , The Australian Addiction ... the suggestion. The centre’s Director and natural healing ... suffering from mental health issues have no voice. I ...
Breaking Medicine News(10 mins):Health News:Daimer Ships Carpet Cleaners for Car Detailing Steam Cleaner Tasks 2Health News:Daimer Ships Carpet Cleaners for Car Detailing Steam Cleaner Tasks 3Health News:Pine Nut Oil is a Proven Remedy for Stomach Ulcers 2Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2Health News:Involuntary Detention Proposal Dehumanizing, Says Holistic Mental Health Service Provider The Australian Addiction And Trauma Treatment Centre 2Health News:Involuntary Detention Proposal Dehumanizing, Says Holistic Mental Health Service Provider The Australian Addiction And Trauma Treatment Centre 3
... Do,Lunch, Inc. is bringing women with alopecia areata ... different from a traditional,support group, the non-profit,s dining ... public awareness. Founder and president,Thea Chassin, bald for ... the,country. According to Chassin, "Our congenial approach is ...
... Brochure as Key Patient Resource on Restorative Options, ... Dental,Association (PDA) is recommending that PDA member dentists ... Association (ADA) when discussing,restorative options with patients., ... give,patients the latest information on oral health issues," ...
... A new study shows that exposure to a chemical ... be harmful to the nose and airways of mice. ... (NIEHS), part of the National Institutes of Health, conducted ... obliterative bronchiolitis (OB) in humans. OB is a debilitating ...
... Surgery is the only curative treatment in patients ... concept a reliable diagnostic procedure is of great ... growth along the bile duct, imaging techniques including ... of limited sensitivity for the detection of bile ...
... Society invites medical and science reporters to attend a special ... learn whats new in the fight against cancer and hear ... Society. This informative media briefing will offer the latest trends ... research, prevention, early detection, patient services, and more. , The ...
... consumption increases the risk of ESCC. There are synergetic ... The risk of ESCC in moderate-to-heavy drinkers, ALDH2 (1/2) ... with the CYP2E1 (c1/c1) genotype; leads to synergetic interactions, ... + 2/2); ALDH2 (1/1) + CYP2E1 (c1/c2 + c2/c2). ...
Cached Medicine News:Health News:In Northern California Bald Women Get Their Heads Together 2Health News:Pennsylvania Dental Association Urges Members to Use New ADA Educational Material 2Health News:Rodent study finds artificial butter chemical harmful to lungs 2Health News:American Cancer Society science reporters briefing to feature latest developments in cancer 2Health News:American Cancer Society science reporters briefing to feature latest developments in cancer 3Health News:Alcohol consumption and polymorphisms of cytochromes P4502E1 are high risks for ESCC 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: